Catalent (CTLT) Revenue & Revenue Breakdown

Overview ForecastOwnership Financials Chart

Catalent Revenue Highlights

Latest Revenue (Y)

$4.38B

Latest Revenue (Q)

$1.02B

Main Segment (Y)

PharmaConsumerHealth

Main Geography (Y)

UNITED STATES

Catalent Revenue by Period

Catalent Revenue by Year

Date	Revenue	Change
2024-06-30	$4.38B	2.46%
2023-06-30	$4.28B	-11.43%
2022-06-30	$4.83B	20.76%
2021-06-30	$4.00B	29.21%
2020-06-30	$3.09B	22.89%
2019-06-30	$2.52B	2.22%
2018-06-30	$2.46B	18.70%
2017-06-30	$2.08B	12.30%
2016-06-30	$1.85B	0.94%
2015-06-30	$1.83B	0.17%
2014-06-30	$1.83B	1.52%
2013-06-30	$1.80B	6.22%
2012-06-30	$1.69B	10.64%
2011-06-30	$1.53B	-

Catalent generated $4.38B in revenue during NA 2024, up 2.46% compared to the previous quarter, and up 173.99% compared to the same period a year ago.

Catalent Revenue by Quarter

Date	Revenue	Change
2024-09-30	$1.02B	-21.37%
2024-06-30	$1.30B	21.14%
2024-03-31	$1.07B	4.88%
2023-12-31	$1.02B	4.28%
2023-09-30	$982.00M	-8.05%
2023-06-30	$1.07B	2.99%
2023-03-31	$1.04B	-9.75%
2022-12-31	$1.15B	12.43%
2022-09-30	$1.02B	-22.16%
2022-06-30	$1.31B	3.14%
2022-03-31	$1.27B	4.60%
2021-12-31	$1.22B	18.73%
2021-09-30	$1.02B	-13.72%
2021-06-30	$1.19B	12.79%
2021-03-31	$1.05B	15.65%
2020-12-31	$910.80M	7.70%
2020-09-30	$845.70M	-10.75%
2020-06-30	$947.60M	24.59%
2020-03-31	$760.60M	5.43%
2019-12-31	$721.40M	8.53%
2019-09-30	$664.70M	-8.41%
2019-06-30	$725.70M	17.52%
2019-03-31	$617.50M	-0.88%
2018-12-31	$623.00M	12.90%
2018-09-30	$551.80M	-19.48%
2018-06-30	$685.30M	9.14%
2018-03-31	$627.90M	3.56%
2017-12-31	$606.30M	11.47%
2017-09-30	$543.90M	-11.83%
2017-06-30	$616.90M	15.83%
2017-03-31	$532.60M	10.11%
2016-12-31	$483.70M	9.38%
2016-09-30	$442.20M	-16.91%
2016-06-30	$532.20M	21.51%
2016-03-31	$438.00M	-3.72%
2015-12-31	$454.90M	7.54%
2015-09-30	$423.00M	-17.08%
2015-06-30	$510.10M	14.22%
2015-03-31	$446.60M	-2.02%
2014-12-31	$455.80M	8.96%
2014-09-30	$418.30M	-19.50%
2014-06-30	$519.60M	14.68%
2014-03-31	$453.10M	2.81%
2013-12-31	$440.70M	6.37%
2013-09-30	$414.30M	-17.99%
2013-06-30	$505.20M	13.02%
2013-03-31	$447.00M	2.50%
2012-12-31	$436.10M	5.85%
2012-09-30	$412.00M	-

Catalent generated $1.02B in revenue during Q1 2025, up -21.37% compared to the previous quarter, and up 95.79% compared to the same period a year ago.

Catalent Revenue Breakdown

Catalent Revenue Breakdown by Product

Annual Revenue by Product

Product/Service	Jun 24	Jun 22	Jun 21	Jun 20	Jun 19
PharmaConsumerHealth	$2.43B	-	-	-	-
Biologics	$1.95B	$2.55B	$1.93B	$1.02B	-
Clinical Supply Services	-	$400.00M	-	-	-
Softgel and Oral Technologies	-	$1.25B	$1.01B	$1.06B	-
Oral and Specialty Delivery	-	$650.00M	$686.00M	$675.90M	-
Softgel Technologies	-	$1.25B	$872.10M	-	-
Oral Drug Delivery	-	$650.00M	$619.90M	-	-
Total Catalent before inter-segment revenue elimination	-	$400.00M	$4.02B	$3.10B	$2.56B
Biologics and Specialty Drug Delivery	-	-	-	-	$742.10M

Catalent's latest annual revenue breakdown by segment (product or service), as of Jun 24: PharmaConsumerHealth (55.46%), and Biologics (44.54%).

Quarterly Revenue by Product

Product/Service	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19
Biologics	$461.00M	$605.00M	$461.00M	$438.00M	$448.00M	$475.00M	$580.00M	$523.00M	$667.00M	$698.00M	$638.00M	$546.00M	$603.30M	$543.70M	$403.90M	-	-	-	-	-
PharmaConsumerHealth	$563.00M	$697.00M	$613.00M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Catalent before inter-segment revenue elimination	-	-	$663.00M	$651.00M	$616.00M	$1.04B	$1.15B	$1.02B	$1.31B	$1.28B	$1.22B	$1.03B	$1.19B	$1.06B	$913.90M	$849.20M	$951.30M	$762.60M	$724.20M	$669.50M
Clinical Supply Services	-	-	-	-	-	-	-	-	$104.00M	-	-	-	$104.80M	-	-	-	$83.60M	-	-	-
Softgel Technologies	-	-	-	-	-	-	-	-	-	$324.00M	$329.00M	$243.00M	$243.70M	$246.60M	$221.10M	$242.30M	$267.90M	$263.70M	-	-
Oral Drug Delivery	-	-	-	-	-	-	-	-	-	$154.00M	$156.00M	$146.00M	$171.70M	$169.90M	$158.30M	$181.40M	$143.20M	$132.60M	-	-
Biologics and Specialty Drug Delivery	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$377.10M	$250.00M	$225.20M	$188.60M	-

Catalent's latest quarterly revenue breakdown by segment (product or service), as of Sep 24: PharmaConsumerHealth (54.98%), and Biologics (45.02%).

Catalent Revenue Breakdown by Country

Annual Revenue by Country

Country	Jun 24	Jun 22	Jun 21	Jun 20	Jun 19
Europe	$1.36B	$1.51B	$1.34B	$976.10M	$842.10M
UNITED STATES	$2.82B	$3.11B	$2.46B	-	-
Softgel and Oral Technologies	-	$1.25B	-	-	-
Oral and Specialty Delivery	-	$650.00M	-	-	-
Clinical Supply Services	-	-	-	-	-
Biologics	-	$2.55B	-	-	-
Total Catalent before inter-segment revenue elimination	-	$4.84B	-	-	-
North America	-	-	-	$1.82B	$1.32B

Catalent's latest annual revenue breakdown by geography, as of Jun 24: UNITED STATES (67.50%), and Europe (32.50%).

Quarterly Revenue by Country

Country	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19
North America	$658.00M	$690.00M	$653.00M	$645.00M	$685.00M	$734.00M	$697.00M	$847.00M	$793.00M	$630.00M	$670.00M	$535.30M	$516.90M	$606.30M	$438.90M	$414.70M	$362.30M	-	-	-
Europe	$331.00M	$416.00M	$345.00M	$324.00M	$274.00M	$306.00M	$356.00M	$274.00M	$411.00M	$373.00M	$370.00M	$351.00M	$388.20M	$344.90M	$326.40M	$281.40M	$286.00M	$258.70M	$221.40M	$210.10M
Total Catalent before inter-segment revenue elimination	-	-	-	-	-	-	$1.15B	-	-	-	-	-	-	-	-	-	-	-	-	-
Biologics	-	-	-	-	-	-	$580.00M	-	-	-	-	-	-	-	-	-	-	-	-	-

Catalent's latest quarterly revenue breakdown by geography, as of Sep 24: North America (66.53%), and Europe (33.47%).

Catalent Peer Comparison by Revenue

Ticker	Company	Last Year Revenue	Last Quarter Revenue
BIO	Bio-Rad Laboratories	$2.67T	$649.73M
IQV	IQVIA	$14.98B	$3.90B
CTLT	Catalent	$4.38B	$1.02B
CRL	Charles River Laboratories	$4.13B	$1.03B
TFX	Teleflex	$2.97B	$764.38M
WST	West Pharmaceutical Services	$2.95B	$746.90M

CTLT Revenue FAQ

What is Catalent’s yearly revenue?

Catalent's yearly revenue for 2024 was $4.38B, representing an increase of 2.46% compared to 2023. The company's yearly revenue for 2023 was $4.28B, representing a decrease of -11.43% compared to 2022. CTLT's yearly revenue for 2022 was $4.83B, representing an increase of 20.76% compared to 2021.

What is Catalent’s quarterly revenue?

Catalent's quarterly revenue for Q1 2025 was $1.02B, a -21.37% decrease from the previous quarter (Q4 2024), and a 4.18% increase year-over-year (Q1 2024). The company's quarterly revenue for Q4 2024 was $1.3B, a 21.14% increase from the previous quarter (Q3 2024), and a 21.82% increase year-over-year (Q4 2023). CTLT's quarterly revenue for Q3 2024 was $1.07B, a 4.88% increase from the previous quarter (Q2 2024), and a 3.57% increase year-over-year (Q3 2023).

What is Catalent’s revenue growth rate?

Catalent's revenue growth rate for the last 3 years (2022-2024) was -9.26%, and for the last 5 years (2020-2024) was 41.58%.

What are Catalent’s revenue streams?

Catalent's revenue streams in n 24 are PharmaConsumerHealth, and Biologics. PharmaConsumerHealth generated $2.43B in revenue, accounting 55.46% of the company's total revenue Biologics generated $1.95B in revenue, accounting 44.54% of the company's total revenue, down -23.42% year-over-year.

What is Catalent’s main source of revenue?

For the fiscal year ending Jun 24, the largest source of revenue of Catalent was PharmaConsumerHealth. This segment made a revenue of $2.43B, representing 55.46% of the company's total revenue.